Key points are not available for this paper at this time.
Cross-sectional and longitudinal monitoring of pRNFL is useful as a biomarker for prediction of physical and cognitive disability progression in patients with RRMS in everyday clinical practice.
Bsteh et al. (Thu,) studied this question.